Amoxicillin News and Research

RSS

Antibiotics program of Giant Eagle results in more than $3M in free prescriptions for customers

Pittsburgh-based food and fuel retailer Giant Eagle, Inc. launched its free antibiotics program in September of 2009, and is pleased to announce that the program has resulted in more than $3 million in free prescriptions for customers in the company's four-state operating area.

15 Feb 2010

Solantic offers $5 prescriptions

Solantic walk-in urgent care, Florida’s fastest-growing provider of urgent care, wellness and employer health services, today announced it is offering $5 prescriptions to its patients whose conditions require prescribed medications.

12 Feb 2010

Moxifloxacin more favorable than amoxicillin/clavulanate for COPD exacerbations

Chronic obstructive pulmonary disease (COPD) affects a large number of subjects worldwide and is characterised by a progressively rising epidemiological, clinical and socio-economic impact. The objectives of treatment are to decrease the burden of the disease through relief of symptoms, improvement of exercise tolerance, and prevention and treatment of exacerbations.

21 Jan 2010

Kenta Biotech and Rentschler Biotechnologie sign agreement to develop antibody against MRSA

Kenta Biotech today announced an agreement with Rentschler Biotechnologie for the development of a fully human monoclonal antibody against methicillin-resistant Staphylococcus aureus (MRSA).

18 Jan 2010

Majority of Canadians confuse sinusitis with H1N1 symptoms

It's winter, that great Canadian season of snow, ice, grey skies...and colds and the flu. In a year when H1N1 is high on everyone's radar, it is more important than ever for Canadians to know what their symptoms mean and when they should see their doctor.

17 Dec 2009

New licensing agreement to develop and commercialize prophylactic vaccine against MRSA signed

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that it has entered into an exclusive, world-wide licensing agreement with Syntiron to develop and commercialize its prophylactic vaccine against Staphylococcus, including Methicillin-Resistant Staphylococcus aureus or MRSA.

17 Dec 2009

Middlebrook Pharmaceuticals announces financial and operational results for third quarter 2009

MiddleBrook Pharmaceuticals, Inc. today announced its financial and operational results for the quarter ended Sept. 30, 2009.

5 Nov 2009

Study reveals LOAD therapy can eliminate bacterium in patients with gastritis and peptic ulcers

Helicobater pylori, a bacteria implicated in peptic ulcers and gastritis, was eradicated in 95 percent patients who took a 7-day course of combination therapy with levofloxacin, omeprazole, nitazoxanide (Alinia®) and doxycycline (LOAD) compared to eradication in only 80.9 percent of patients on lansoprazole, amoxicillin and clarithromycin (LAC) for seven days.

27 Oct 2009

Giant Eagle offers generic prescription antibiotics for free at its in-store pharmacies

At a time when many families affected by a difficult economy are struggling with the costs of prescription medications, supermarket retailer Giant Eagle, Inc. is making ten broadly used generic prescription antibiotics in 46 common dosages available for free every day at all of its 210 in-store pharmacies.

4 Sep 2009

Fluxion Biosciences receives a $1.8 million NIH grant for developing microfluidic platform

Fluxion Biosciences, a leading developer of microfluidic systems for functional cell analysis, today announced that it has received a $1.8 million NIH grant for the development of a high-throughput screening platform for anti-microbial drug discovery.

From Fluxion Biosciences 20 Aug 2009

Antibiotic prescribing should be standardized across Europe to help tackle resistance

Antibiotic prescribing for respiratory illnesses should be standardised across Europe to help reduce inappropriate prescribing and resistance, say experts in a study published on bmj.com.

24 Jun 2009

Antibiotics diminish diversity of helpful gutmicrobes

It's common knowledge that a protective navy of bacteria normally floats in our intestinal tracts. Antibiotics at least temporarily disturb the normal balance. But it's unclear which antibiotics are the most disruptive, and if the full array of "good bacteria" return promptly or remain altered for some time.

18 Jun 2009

Why does aspirin increase the susceptibility of Helicobacter pylori to antimicrobials?

Resent studies reported that aspirin inhibited the growth of H. pylori in a dose-dependent manner and significantly affected the activity of virulence factors of H. pylori.

2 Apr 2009

Why does aspirin increase the susceptibility of Helicobacter pylori to antimicrobials?

Resent studies reported that aspirin inhibited the growth of H. pylori in a dose-dependent manner and significantly affected the activity of virulence factors of H. pylori.

3 Mar 2009

Bacteria-killing enzyme cures mice with fatal pneumonia

Before the advent of antibiotics, pneumonia claimed so many lives - and was so feared - that it was called the "captain of the ship of death."

1 Mar 2009

Drug combo shows potential for treating extensively drug resistant tuberculosis

A combination of two FDA-approved drugs, already approved for fighting other bacterial infections, shows potential for treating extensively drug resistant tuberculosis (XDR-TB), the most deadly form of the infection.

26 Feb 2009

WHO receives funds for children's medicines research with UNICEF

WHO has received US$ 9.7 million in grant from the Bill & Melinda Gates Foundation to work with UNICEF to conduct crucial research in children's medicines, with the aim of increasing the number of child-size medicines designed and formulated specifically for children.

21 Jan 2009

FDA issues complete response letter for Ceftobiprole for treatment of complicated skin infections

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ceftobiprole for the treatment of complicated skin and skin structure infections, including diabetic foot infections.

26 Nov 2008

An ideal therapy for peptic ulcer disease

Since the discovery of the etiological role of Helicobacter pylori (H pylori) in peptic ulcer disease, its eradication became the main objective of therapy, and several treatment regimens were developed.

11 Nov 2008

Experts say children with severe pneumonia are better off being treated at home

The World Health Organisation (WHO) says children with severe pneumonia are better off being treated at home instead of sending them to hospital.

6 Jan 2008

Amoxicillin News and Research

Antibiotics program of Giant Eagle results in more than $3M in free prescriptions for customers

Solantic offers $5 prescriptions

Moxifloxacin more favorable than amoxicillin/clavulanate for COPD exacerbations

Kenta Biotech and Rentschler Biotechnologie sign agreement to develop antibody against MRSA

Majority of Canadians confuse sinusitis with H1N1 symptoms

New licensing agreement to develop and commercialize prophylactic vaccine against MRSA signed

Middlebrook Pharmaceuticals announces financial and operational results for third quarter 2009

Study reveals LOAD therapy can eliminate bacterium in patients with gastritis and peptic ulcers

Giant Eagle offers generic prescription antibiotics for free at its in-store pharmacies

Fluxion Biosciences receives a $1.8 million NIH grant for developing microfluidic platform

Antibiotic prescribing should be standardized across Europe to help tackle resistance

Antibiotics diminish diversity of helpful gutmicrobes

Why does aspirin increase the susceptibility of Helicobacter pylori to antimicrobials?

Why does aspirin increase the susceptibility of Helicobacter pylori to antimicrobials?

Bacteria-killing enzyme cures mice with fatal pneumonia

Drug combo shows potential for treating extensively drug resistant tuberculosis

WHO receives funds for children's medicines research with UNICEF

FDA issues complete response letter for Ceftobiprole for treatment of complicated skin infections

An ideal therapy for peptic ulcer disease

Experts say children with severe pneumonia are better off being treated at home

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News